Dr Shahab is an Associate Professor in Health Psychology at University College London. He trained in psychology, epidemiology and neuroscience and has more than 15 years’ experience in addiction research, tobacco control and health psychology. Dr Shahab’s expertise spans work on novel behavioural and pharmacological smoking cessation interventions, biomarkers, tobacco product regulation and policy, digital health and tobacco and alcohol use epidemiology. He is a Senior Editor for the journal Addiction and Academic Editor for Plos One and IJERPH. Dr Shahab has collaborated with academic as well as non-academic (e.g. governmental and non-governmental) partners and to date has authored over 100 scientific papers, reports and reviews in this area.

Carole Clair is a general internist and a researcher, and is the co-head of the Department of Education, Research and Innovation at the Center for Primary Care and Public Health at the University of Lausanne, Switzerland. She works as a lecturer and shares her time between teaching, clinical activities in general internal medicine and smoking cessation clinic and research. Her main research interest is the interaction between smoking and metabolism. Dr. Clair is the principal investigator of randomized controlled trial assessing the efficacy and metabolic impact of a smoking cessation intervention in people with type 2 diabetes. Since 2013, she is an Associate Editor for SRNT’s journal Nicotine and Tobacco Research. She is the chair of the local organising committee for the 2020 SRNT-E conference, which will be held in Lausanne, Switzerland.

Daniel Kotz is professor in general practice with a main focus on addiction research and clinical epidemiology at the Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf. He is also affiliated with Maastricht University, University College London, and the University of Edinburgh. His main research areas are tobacco addiction (effectiveness of behavioural and pharmacological treatments), chronic obstructive pulmonary disease (prediction modelling, early detection, prevention) and clinical epidemiology (research methodology and reporting). In the field of tobacco addiction he is currently leading a 5-year research program entitled "Treating tobacco addiction: new clinical approaches" and a cluster-RCT entitled “Training general practitioners in brief stop-smoking advice”. He is also co-investigator of an effectiveness-implementation of tobacco cessation within TB programmes. Prof Kotz is Associate Editor of the Journal of Clinical Epidemiology and Senior Editor of Addiction. He previously served SRNT in his role of SRNT-E board member from 2009-2012 and as co-chair of the SRNT conference in Florence in 2017.

Ute Mons currently heads the Cancer Prevention Unit and the WHO Collaborating Centre for Tobacco Control at the German Cancer Research Center (DKFZ) based in Heidelberg, Germany. She holds an M.A. in Sociology and Economics, and a PhD in Epidemiology and Public Health from the University of Heidelberg. She has co-authored more than 100 research publications, mostly in her main research areas tobacco control, cancer prevention, and chronic disease epidemiology. In these areas, Ute Mons is involved in several national and international research projects, including being PI of the International Tobacco Control Policy Evaluation Project (ITC) Germany project. Ute Mons also participates in several national committees to promote public health and tobacco control. In 2017, she was awarded one of the ECL ECTOH Young Professional Awards recognizing her contribution to tobacco control.

Lynne Dawkins is an Associate Professor of Psychology at the School of Applied Science of London South Bank University. She has worked in the field of nicotine and tobacco research for 20 years and was among the first to demonstrate specific abstinence-related cognitive and motivational impairments in smokers, to map trajectories of recovery, and predictive utility for cessation. In part of her research she pioneered in the field of e-cigarettes describing user profiles and patterns of use; effects on cigarette craving/withdrawal symptoms; device characteristics and comparisons; puffing topographies, and pharmacokinetic profiles. This work has fed into UK Tobacco Control Policy. Dr Dawkins is currently in receipt of CRUK funding to explore effects of nicotine e-liquid concentrations on puffing patterns and carbonyl exposure and effects of the TPD E-cigarette warning labels on risk perceptions/intentions to use.

Mirte Kuipers works as a postdoctoral researcher at the Department of Public Health, Amsterdam UMC-University of Amsterdam. Mirte studies the impact of tobacco control policies on smoking in young people and adults. She is involved in research in the Netherlands, the UK, and in the wider European context, and in a project on tobacco control in Indonesia. She applies quantitative methods, including trend analyses, cross-country comparisons and quasi-experimental studies. Mirte currently leads a project on the impact of tobacco control policies at the point of sale on adolescents' exposure to tobacco products and advertising and smoking behaviour, using geographical and epidemiological methods. She is an Associate Editor for Addiction.

Dr Notley collaboratively leads the UEA Addiction Research Group. She is a social scientist with extensive experience in smoking cessation, relapse prevention and tobacco harm reduction research. Her current programme of research is focused on tobacco smoking relapse prevention, particularly working with post-partum women and vulnerable groups. She is an Associate Editor for Addiction and Nicotine and Tobacco Research.

Marcus Munafo is Professor of Biological Psychology at the School of Experimental Psychology, University of Bristol. Prof Munafò’s research focuses on understanding pathways into, and the consequences of, health behaviours and mental health, with a particular focus on tobacco and alcohol use. This work includes: 1) observational and genetic epidemiology, and the use of a range of methods that enable stronger causal inference from observational data, such as negative control and Mendelian randomization methods; 2) the laboratory study of cognitive and neurobiological mechanistic pathways that underpin exposure-outcome relationships; and 3) the development of novel individual- and population-level interventions that target these mechanisms, including choice architecture interventions. This work has informed ongoing policy debates, such as the introduction of standardised (“plain”) packaging for tobacco products. He also has interests in the role of incentive structures in science, and the extent to which these shape the robustness and reproducibility of scientific research. Professor Munafo is Editor-in-Chief of SRNT’s journal Nicotine and Tobacco Research.